M M Hasibuzzaman

Targeting the Toll/Interleukin-1 Receptor Family as an Immunotherapeutic Strategy for Head and Neck Squamous Cell Carcinoma

283 EMRB Seebohm Conference Room
Degree major
Human Toxicology
Chair(s)
Andrean Burnett